ArticleBMJ oncology2024

Integrated multiplex analysis of cell death regulators in stage II colorectal cancer suggests patients with 'persister' cell profiles fail to benefit from adjuvant chemotherapy.

Sanghee Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.